You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Syringes Articles
Popular Syringes Articles
Highly Recommended Syringes Articles
Send a link to this page to your friends and colleagues.
In March a U.S. District Court issued a preliminary injunction in favor of Becton Dickinson, a major manufacturer of insulin pens and needles, in its false and misleading advertising suit against its Danish competitor, Novo Nordisk. The court prohibited Novo Nordisk from claiming that its NovoPen 1.5 and Novolin Pre-filled devices can only be used with NovoFine needles.
"Diabetics are entitled to benefit from compatible components (i.e., those manufactured by Becton) when they are available," the ruling noted.
This recent ruling is only one in the legal battle that began in December 1996, when Novo Nordisk alleged that Becton was infringing on its U.S. patent and trademark on NovoPen. The next month Becton filed a counter suit against Novo. The suit alleged false and misleading advertising and unfair competition when it stated in its product literature that the Novo-manufactured pens could only be used with Novo-manufactured needles. Novo brought a suit in mid 1997 against Becton and Eli Lilly seeking to block sales of Becton's insulin pen needles and cartridges manufactured by Lilly. The case was heard along with Becton's false advertising counterclaim.
No trial date has been set in either of the patent infringement suits.
Categories: Diabetes, Insulin, Novo Nordisk, Pens, Syringes
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...